Athersys Inc ATHX:NASDAQ

Last Price$0.25NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/24/22

Today's Change0(0.00%)
Bid (Size)$0.25 (9)
Ask (Size)$0.26 (7)
Day Low / HighN/A - N/A
Volume26.3 M
 

View Biotechnology IndustryPeer Comparison as of 06/24/2022

 

Athersys Inc ( NASDAQ )

Price: $0.25
Change: -0.02 (7.35%)
Volume: 26.3 M
4:00PM ET 6/24/2022
 
 

Solid Biosciences Inc ( NASDAQ )

Price: $0.58
Change: -0.02 (2.83%)
Volume: 8.0 M
4:00PM ET 6/24/2022
 
 

Infinity Pharmaceuticals Inc ( NASDAQ )

Price: $0.73
Change: -0.10 (11.89%)
Volume: 10.0 M
4:00PM ET 6/24/2022
 
 

Opiant Pharmaceuticals Inc ( NASDAQ )

Price: $12.64
Change: +0.44 (3.61%)
Volume: 14.7 K
4:00PM ET 6/24/2022
 
 

Akebia Therapeutics Inc ( NASDAQ )

Price: $0.37
Change: -0.03 (7.12%)
Volume: 24.0 M
4:00PM ET 6/24/2022
 

Read more news Recent News

Wall Street Set to Open Higher
9:16AM ET 6/17/2022 MT Newswires

US stocks look set to open Friday trading higher as Federal Reserve Chairman Jerome Powell speaks before the inaugural Conference on the International...

US Futures Move Higher Friday
8:16AM ET 6/17/2022 MT Newswires

US stock futures are moving higher during Friday's premarket session ahead of remarks to be given by Federal Reserve Chairman Jerome Powell before the...

Top Premarket Gainers
7:51AM ET 6/17/2022 MT Newswires

Revlon (REV) shares surged 86%, rebounding from Thursday's volatile session following the company's announcement of filing for Chapter 11 bankruptcy...

Athersys Reducing Workforce by 70% to Cut Costs -- Shares Fall 7% After-Hours
5:40PM ET 6/02/2022 MT Newswires

Athersys (ATHX) said Thursday it is cutting its workforce by up to 70% as part of its restructuring plan to lower costs and focus on existing clinical...

View all Commentary and Analysis

Athersys (ATHX) Investor Presentation Treasure Data - Slideshow
1:31PM ET 5/26/2022 Seeking Alpha

Athersys: Focus On Stroke
9:40AM ET 5/04/2022 Seeking Alpha

Athersys - Hero Or Zero Opportunity
10:56AM ET 4/18/2022 Seeking Alpha

Athersys, Inc. (ATHX) CEO Daniel Camardo on Q4 2021 Results - Earnings Call Transcript
8:47PM ET 3/15/2022 Seeking Alpha

Company Profile

Business DescriptionAthersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH. View company web site for more details
Address3201 Carnegie Avenue
Cleveland, Ohio 44115-2634
Phone+1.216.431.9900
Number of Employees75
Recent SEC Filing06/23/20224
Chief Executive Officer & DirectorDaniel A. Camardo
Chief Operating OfficerMaia A. Hansen
Chief Financial & Accounting OfficerIvor MacLeod
Head-Information Technology & CommunicationsRakesh Ramachandran

Company Highlights

Price Open$0.27
Previous Close$0.28
52 Week Range$0.18 - 1.81
Market Capitalization$64.2 M
Shares Outstanding252.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.35
Beta vs. S&P 500N/A
Revenue$24.3 M
Net Profit Margin-981.52%
Return on Equity-429.24%

Analyst Ratings as of 06/02/2022

Buy
1
Overweight
0
Hold
0
Underweight
1
Sell
1
Consensus RecommendationConsensus Icon
Powered by Factset